Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 347
Aptamer sequence: UCUGAGGGGUUGGGGCCGCAGUCUCGUCGCCAUGGCUAACGAGGCCGGAACUAGUUUUAGCCGAAAUGAUCGAUGC
Target unique ID: 6140
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_1057 421 Molecule Phenylalanine 1.0 mM 50 mM Hepes (pH 7.0), 0.3 M NaCl, 5 mM CaCl2, and 5 mM MgCl2 11847556
Structure information of aptamer
Aptamer Sequence: UCUGAGGGGUUGGGGCCGCAGUCUCGUCGCCAUGGCUAACGAGGCCGGAACUAGUUUUAGCCGAAAUGAUCGAUGC
The optimal secondary structure in dot-bracket notation: .((((((..((((..(((..(((((((.((....))..))))))))))..)))))))))).(((.....)))....
The centroid secondary structure in dot-bracket notation: .((((((..((((..(((..(((((((.((....))..))))))))))..)))))))))).(((.....)))....
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_1057 Description 421
Aptamer chemistry RNA Length 76 nt
GC content 57.9% Molecular weight 23,572.05 Da
Molarity of 1 μg/μl solution 42.42 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Aptasensor
Sequence UCUGAGGGGUUGGGGCCGCAGUCUCGUCGCCAUGGCUAACGAGGCCGGAACUAGUUUUAGCCGAAAUGAUCGAUGC
Applications Determination of phenylalanine
Target information
Type Detail Type Detail
PubChem ID 6140 Molecular name Phenylalanine
Molecular formula C9H11NO2 Molecular weight 165.19
IUPAC name (2S)-2-amino-3-phenylpropanoic acid InChIKey COLNVLDHVKWLRT-QMMMGPOBSA-N
LogP 0.641 Topological polar surface area 63.32
Hydrogen bond acceptor 2 Hydrogen bond donor 2

Synonym(s):
L-phenylalanine; phenylalanine; 63-91-2; (S)-2-Amino-3-phenylpropanoic acid; 3-Phenyl-L-alanine; (2S)-2-amino-3-phenylpropanoic acid; (S)-Phenylalanine; (S)-2-Amino-3-phenylpropionic acid; beta-Phenyl-L-alanine; (L)-Phenylalanine; 3-Phenylalanine; H-Phe-OH; Antibiotic FN 1636; L-Alanine, phenyl-; Alanine, 3-phenyl-; L-Antibiotic FN 1636; (S)-alpha-Amino-beta-phenylpropionic acid; L-Alanine, 3-phenyl-; Phenylalanine (VAN); Fenilalanina [Spanish]; Phenylalaninum [Latin]; (S)-alpha-Aminohydrocinnamic acid; Alanine, phenyl-, L-; (S)-(-)-Phenylalanine; beta-Phenylalnine, (-)-; (S)-alpha-Amino-benzenepropanoic acid; FEMA No. 3585; Phenylalanine, L-; Hydrocinnamic acid, alpha-amino-; 2-Amino-3-phenylpropionic acid, L-; Phenylalanine [USAN:INN:JAN]; HSDB 1825; alpha-Aminohydrocinnamic acid, L-; alpha-Amino-beta-phenylpropionic acid, L-; Benzenepropanoic acid, alpha-amino-, (S)-; fenilalanina; alpha-Aminohydrocinnamic acid; endophenyl; NSC 79477; L-Phe; UNII-47E5O17Y3R; L-PHENYLALININE; MFCD00064227; 67675-33-6; CHEMBL301523; CHEBI:17295; L-2-Amino-3-phenylpropionic acid; phe; 47E5O17Y3R; Phenylalaninum; phenylalanin; Phenylalamine; Phenylalanine (L-Phenylalanine); Alanine, phenyl-; .beta.-Phenylalanine; Phenyl-.alpha.-alanine; L-.beta.-Phenylalanine; .beta.-Phenyl-L-alanine; (-)-.beta.-Phenylalanine; EINECS 200-568-1; .alpha.-Aminohydrocinnamic acid; .beta.-Phenyl-.alpha.-alanine; Phenylalanine (USP/INN); L-phenylaniline; Hydrocinnamic acid, .alpha.-amino-; NSC-9959; CCRIS 4254; .beta.-Phenyl-.alpha.-alanine, l-; NSC-79477; L-phenyl Alanine; PheOH; 1usi; NCI9959; (-)-phenylalanine; .alpha.-Amino-.beta.-phenylpropionic acid; racemic phenylalanine; Phenylalanine [USAN:USP:INN:JAN]; 1f2p; alpha-Aminohydrocinnamate; (-)-beta-Phenylalanine; L-Phenylalanine, 99%; beta-Phenyl-alpha-alanine; L-Phenylalanine (JP17); bmse000045; bmse000900; bmse000921; bmse001016; SCHEMBL8119; NCIStruc1_000204; NCIStruc2_000248; H-Phe-2-Chlorotrityl Resin; L-(-)-PHENYLALANINE; (S)-alpha-Aminohydrocinnamate; L-Phenylalanine (H-Phe-OH); L-2-Amino-3-phenylpropionate; L-Phenylalanine, 99%, FCC; GTPL3313; (S)-alpha-Aminobenzenepropanoate; 3-Amino-4-phenyl-butanoic acid; DTXSID4040763; (S)-2-amino-3-phenylpropanoate; BDBM18073; (S)-2-Amino-3-phenylpropionate; 1F9436B3-8B0D-4AC6-A004-4249B0BDA436; L-Phenylalanine non-animal source; (S)-alpha-Amino-benzenepropanoate; ZINC105196; HY-N0215; L-2-amino-3-phenyl-propionic acid; (S)-alpha-Aminobenzenepropanoic acid; AC8117; CCG-37572; NCGC00013103; L-[2,3,4,5,6-3H]phenylalanine; (S)-alpha-Amino-beta-phenylpropionate; AKOS010373257; AKOS015853585; L-Phenylalanine, Cell Culture Reagent; (S)-.alpha.-Aminobenzenepropanoic acid; DB00120; L-Phenylalanine, Vetec(TM), 98.5%; MCULE-5960921520; L-Phenylalanine, reagent grade, >=98%; NCGC00013103-02; NCGC00013103-03; NCGC00013103-04; NCGC00013103-05; NCGC00095047-01; NCGC00095047-02; NCGC00095047-03; NCGC00095047-04; AC-22417; AS-14129; BP-20538; K018; AB0013977; DB-029978; L-Phenylalanine, 99%, natural, FCC, FG; AM20060774; P0134; Benzenepropanoic acid, .alpha.-amino-, (S)-; L-Phenylalanine, BioUltra, >=99.0% (NT); 63P912; A20654; C00079; D00021; M02961; 34149-EP2289892A1; 34149-EP2301939A1; 34149-EP2305688A1; 34149-EP2305825A1; 34149-EP2311850A1; L-Phenylalanine, SAJ special grade, >=99.0%; 125851-EP2284178A2; 125851-EP2284179A2; 125851-EP2295422A2; Q170545; L-Phenylalanine, Vetec(TM) reagent grade, >=98%; Q-201326; F0001-2360; Z1258578341; L-Phenylalanine, certified reference material, TraceCERT(R); UNII-0O72R8RF8A component COLNVLDHVKWLRT-QMMMGPOBSA-N; UNII-8P946UF12S component COLNVLDHVKWLRT-QMMMGPOBSA-N; UNII-N7U7BXP2OI component COLNVLDHVKWLRT-QMMMGPOBSA-N; Phenylalanine, European Pharmacopoeia (EP) Reference Standard; 3-(2-AMINOETHYL)-1,3-THIAZOLIDINE-2,4-DIONEHYDROCHLORIDE; L-Phenylalanine, United States Pharmacopeia (USP) Reference Standard; L(-)-phenylalanine; Beta-phenylalanine;Dl-2-amino-3-phenylpropanoic acid;; L-Phenylalanine, analytical standard, for Nitrogen Determination According to Kjeldahl Method; L-Phenylalanine, Pharmaceutical Secondary Standard; Certified Reference Material; L-Phenylalanine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%; L-Phenylalanine, PharmaGrade, Ajinomoto, EP, JP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture

Activity data

No relevant experimental diagram

Interaction ID 347
Target type Molecule
Target unique ID 6140
Activity 1.0 mM
Binding Conditions/Buffer

50 mM Hepes (pH 7.0), 0.3 M NaCl, 5 mM CaCl2, and 5 mM MgCl2

Assay

N/A

PubMed ID 11847556
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_382 RNA GGCGUGACCUGAUGAGUCACGCAGACGCUAGCGAAUUGGUUCCUCGAAAGGGGAAAGCGUUAUUAAGAAACCAAAAUGUGUUACGAAACGUUCCC 52.63%
Apta_645 RNA CUGGACGACGGGGACGCCACUGGACUAGGUAAGCCAGGACCGUACGUCGGGAGCCGUCAGAAUA 52.63%
Apta_123 RNA GGGAGAAAGGGAAGCUUGAGCAGCAGGAGGGCCGGCGUUAGGGUUAGCGAGCCGAUUGAAAGAAGAAGGAACGAGCGUACGGAUCCGAUC 52.22%
Apta_410 RNA GGGAGAGCGGAAGCGUGCUGGGCCUGUCGUUCGCUGUGUCUUGCUACGUUACGUUACACGGUUGGCAUAACCCAGAGGUCGAUGG 51.76%
Apta_892 RNA ACCGAGUCCAGAAGCUUGUAGUACUCAAUACUCAAGCAAGCCCAGCCCUACCAACCCCGGAGCCUAGAUGGAGUUGAAUUCUCCCUAUAGUGAGUCGUAUUAC 51.46%
Apta_895 RNA ACCGAGUCCAGAAGCUUGUAGUACUACCGCAACGUUGGCGUUCGGCGUUGGCCGCGUCAUCGCUAGCCUAGAUGGAGUUGAAUUCUCCCUAUAGUGAGUCGUAUUAC 51.40%
Apta_431 RNA CAGGCAUGCCUAGCUAAGCAGCCCAUGGCUUAUGCGCGGAAUAUUGGCUUCCGUUC 51.32%
Apta_623 RNA GGGAAUGGAUCCACAUCUACGAAUUCACCGCGGGGUUGCGGACCGGGAGCUCCAGCUUCACUGCAGACUUGACGAAGCUU 51.25%
Apta_1056 RNA GUCAUGUUGUGUUGUGGUCCAUCCUUUUCUACGCCAGUCGAGUCUGUAGCGUGGGAGUAAACUGAACGGUCAGACAGGA 50.63%
Apta_429 RNA GCAUGCAGUGUCUAUUCUCGAGUAGCGAUCGUUGAAGGGGUAUAAGGUUGGCAGAUCGCUAGCAUGCAACUGACUCGGAUAAGCA 50.59%
Apta_886 RNA GGGAGACGAUAUUCGUCCAUUCGGGUGGCCCGUGUCUGAGCGGGGACGGCCACUUGAGCGCCGCUGUCCGACUGAAUUCUCGACC 50.59%
Apta_893 RNA ACCGAGUCCAGAAGCUUGUAGUACUUAUGUCCCAUCGAACGCAGUGUAUCUUGCACCGACUCUCUGCCUAGAUGGAGUUGAAUUCUCCCUAUAGUGAGUCGUAUUAC 50.47%
Apta_894 RNA ACCGAGUCCAGAAGCUUGUAGUACUGACCCUUCCCGACGCACGGACCAGUGAUGCCAACCCACCCGCCUAGAUGGAGUUGAAUUCUCCCUAUAGUGAGUCGUAUUAC 50.47%
Apta_312 RNA GGGAAAAGAGACGGCCGGCGCCAUAGCCGAGAUCCGAGGUGUUGCCGAGAA 50.00%
Apta_496 RNA GGGCUAGCUGAUCGUACCCAGUAGCGUGGCAUGGGGUGCCUAGUCGGGCGAUACUAACAGCUAACACCC 50.00%
Apta_561 RNA GGAUAAUAGCCGUAGGUUGCGAAAGCGACCCUGAUGAGCCUGUGGAAACAGACGUGGCACAUGACUACGUCGAAACGGUAGCGAGAGCUC 50.00%
Apta_563 RNA GGAUAAUAGCCGUAGGUUGCGAAAGCGACCCUGAUGAGAAAGCCAAAGCCGUAGCGCAGAUGAUCUCGCCAUCAGUACCGAAACGGUAGCGAGAGCUC 50.00%
Apta_575 RNA AGAGCUUGACGGUCCCGAGAGUCGAGCCCAAGCUGACACUGGACCUUUGCGGACCACGUGUUGAUCGUCG 50.00%
Apta_724 RNA GGGAGAGGAUACUACUGUCAUACGUUAGGCUGUAGGCGAGGUGAAAUGAGCGGUAAUAGCCUCAGCGUAGCAUAUGCAUGAAUUCGAAGCUUCGC 49.47%
Apta_710 RNA GGAUAAUAGCCGUAGGUUGCGAAAGCGACCCUGAUGAGUCUGGAUACCAUGCAUGAUGCACCUUGGCAGUCUUACGAAACGGUAGCGAGAGCUC 48.94%